DALVANCE CONNECTS Trademark

Trademark Overview

On Thursday, April 16, 2015, a trademark application was filed for DALVANCE CONNECTS with the United States Patent and Trademark Office. The USPTO has given the DALVANCE CONNECTS trademark a serial number of 86599427. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, October 20, 2023. This trademark is owned by Durata Therapeutics Holding C.V.. The DALVANCE CONNECTS trademark is filed in the Insurance & Financial Services category with the following description:

Providing information about patient reimbursement and insurance coverage for pharmaceuticals
dalvance connects

General Information

Serial Number86599427
Word MarkDALVANCE CONNECTS
Filing DateThursday, April 16, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, October 20, 2023
Registration Number5209877
Registration DateTuesday, May 23, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2015

Trademark Statements

Goods and ServicesProviding information about patient reimbursement and insurance coverage for pharmaceuticals

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, April 23, 2015
Primary Code036
First Use Anywhere DateTuesday, May 31, 2016
First Use In Commerce DateTuesday, May 31, 2016

Trademark Owner History

Party NameALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type77 - NOT AVAILABLE
AddressDUBLIN 17 D17 E400
IE
Party NameDurata Therapeutics Holding C.V.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGeorge Town, Grand Cayman KYI-9005
KY
Party NameDurata Therapeutics Holding C.V.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGeorge Town, Grand Cayman KYI-9005
KY
Party NameDurata Therapeutics Holding C.V.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Cayman KYI-9005
KY

Trademark Events

Event DateEvent Description
Friday, October 20, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, October 20, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, October 20, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 24, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, May 23, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, December 19, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 23, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, April 18, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 17, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, April 1, 2017STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 30, 2017USE AMENDMENT FILED
Thursday, March 30, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, March 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 21, 2017SOU EXTENSION 2 GRANTED
Thursday, November 3, 2016SOU EXTENSION 2 FILED
Wednesday, November 2, 2016SOU EXTENSION 1 GRANTED
Tuesday, May 3, 2016SOU EXTENSION 1 FILED
Monday, February 13, 2017PAPER RECEIVED
Tuesday, January 31, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 27, 2017PETITION INQUIRY LETTER ISSUED
Sunday, October 30, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 28, 2016NOTICE OF REVIVAL - E-MAILED
Wednesday, September 28, 2016PETITION GRANTED - EXTENSION REQUEST FILED
Monday, September 26, 2016ASSIGNED TO PETITION STAFF
Friday, September 16, 2016TEAS DUE DILIGENCE PETITION RECEIVED
Monday, June 6, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 6, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 3, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, July 25, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 25, 2015ASSIGNED TO EXAMINER
Thursday, April 23, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 20, 2015NEW APPLICATION ENTERED

Related Keywords

connects dalvance insurance coverage pharmaceuticals reimbursement patient information about providing